Arcellx’s CMO gives an update on their BCMA program at the 2023 CAR-TCR Summit
Chris Heery describes the process relating to bridging therapy that enabled a partial clinical hold to lift.
Also look for unique social pages for BiotechTV U.
#1. Pfizer’s CEO on Q2 earnings.
#2. Moderna CEO Stéphane Bancel on Moderna’s business at its R&D Day in New York
#3. UPenn’s Bruce Levine discusses the progress of CAR-T
#4. Learning about gene writing at Tessera Therapeutics
#5. Visiting Bayer’s Research and Innovation Center in Kendall Square